Gene · 4593
Papers3,141
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,141
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. | Nat Biotechnol | 2023 | 36658341 | PubTator, text mining | PubMed |
| Placental expression of Fatty Acid Desaturases 1, 2 and 3 in selected pregnancy pathologies. | Acta Biochim Pol | 2023 | 36652541 | PubTator, text mining | PubMed |
| Ophthalmologic clinical features of ocular myasthenia gravis. | Medicine (Baltimore) | 2023 | 36637960 | PubTator, text mining | PubMed |
| Analysis of influencing factors of perioperative myasthenic crisis in 387 myasthenia gravis patients without thymoma in a single center. | J Cardiothorac Surg | 2023 | 36635776 | PubTator, text mining | PubMed |
| [Epidemiology of myasthenia gravis in the Iberian Peninsula and Latin America]. | Rev Neurol | 2023 | 36631965 | PubTator, text mining | PubMed |
| Analysis of length of stay and treatment emergent complications in hospitalized myasthenia gravis patients with exacerbation. | BMC Neurol | 2023 | 36631752 | PubTator, text mining | PubMed |
| A very late onset AChR and MuSK double positive myasthenia gravis: a case description and literature review. | Neuromuscul Disord | 2023 | 36628839 | PubTator, text mining | PubMed |
| Epitranscriptomic N6-Methyladenosine Profile of SARS-CoV-2-Infected Human Lung Epithelial Cells. | Microbiol Spectr | 2023 | 36625663 | PubTator, text mining | PubMed |
| Genetic variation in the human olfactory receptor OR5AN1 associates with the perception of musks. | Chem Senses | 2023 | 36625229 | PubTator, text mining | PubMed |
| Disease activity in patients with immune-mediated inflammatory diseases after SARS-CoV-2 vaccinations. | J Autoimmun | 2023 | 36621174 | PubTator, text mining | PubMed |
| Immunological Aspects of Von Hippel-Lindau Disease: A Focus on Neuro-Oncology and Myasthenia Gravis. | Diagnostics (Basel) | 2023 | 36611440 | PubTator, text mining | PubMed |
| Vitamin D receptor gene polymorphisms are associated with the risk and features of myasthenia gravis in the Han Chinese population. | Immunol Res | 2023 | 36609978 | PubTator, text mining | PubMed |
| From phosphorylation to phenotype - Recent key findings on kinase regulation, downstream signaling and disease surrounding the receptor tyrosine kinase MuSK. | Cell Signal | 2023 | 36608736 | PubTator, text mining | PubMed |
| Development and Application of a Cell-Based Assay for LRP4 Antibody Associated With Myasthenia Gravis. | J Clin Neurol | 2023 | 36606647 | PubTator, text mining | PubMed |
| Improving diagnosis of mitochondrial fatty-acid oxidation disorders. | Eur J Hum Genet | 2023 | 36599942 | PubTator, text mining | PubMed |
| Efgartigimod improved health-related quality of life in generalized myasthenia gravis: results from a randomized, double-blind, placebo-controlled, phase 3 study (ADAPT). | J Neurol | 2023 | 36598575 | PubTator, text mining | PubMed |
| N2 Year in Review. | Neurol Neuroimmunol Neuroinflamm | 2023 | 36596717 | PubTator, text mining | PubMed |
| Co-VAN study: COVID-19 vaccine associated neurological diseases- an experience from an apex neurosciences centre and review of the literature. | J Clin Neurosci | 2023 | 36586226 | PubTator, text mining | PubMed |
| A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells. | Hum Mol Genet | 2023 | 36579833 | PubTator, text mining | PubMed |
| Interactions between polycyclic musks and human lactoferrin: Multi-spectroscopic methods and docking simulation. | J Mol Recognit | 2023 | 36573888 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4593/papers?page=32